Medical Care
Global Transdermal Drug Delivery System Market Research Report 2024
- Jan 20, 24
- ID: 21183
- Pages: 96
- Figures: 183
- Views: 32
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
The global Transdermal Drug Delivery System market was valued at US$ 15060 million in 2023 and is anticipated to reach US$ 36450 million by 2030, witnessing a CAGR of 13.3% during the forecast period 2024-2030.
Global Transdermal Drug Delivery System key players include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 45% percent.
In terms of product, Nitroglycerin is the largest segment, with a share over 25%. And in terms of application, the largest application is OTC, followed by RX.
This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Delivery System.
Report Scope
The Transdermal Drug Delivery System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Drug Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
Segment by Type
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Segment by Application
OTC
Rx
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transdermal Drug Delivery System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Transdermal Drug Delivery System market was valued at US$ 15060 million in 2023 and is anticipated to reach US$ 36450 million by 2030, witnessing a CAGR of 13.3% during the forecast period 2024-2030.
Global Transdermal Drug Delivery System key players include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 45% percent.
In terms of product, Nitroglycerin is the largest segment, with a share over 25%. And in terms of application, the largest application is OTC, followed by RX.
This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Delivery System.
Report Scope
The Transdermal Drug Delivery System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Drug Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
Segment by Type
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Segment by Application
OTC
Rx
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transdermal Drug Delivery System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transdermal Drug Delivery System Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fentanyl
1.2.3 Nitroglycerin
1.2.4 Estradiol
1.2.5 Nicotine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Transdermal Drug Delivery System Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 OTC
1.3.3 Rx
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transdermal Drug Delivery System Market Perspective (2019-2030)
2.2 Transdermal Drug Delivery System Growth Trends by Region
2.2.1 Global Transdermal Drug Delivery System Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Transdermal Drug Delivery System Historic Market Size by Region (2019-2024)
2.2.3 Transdermal Drug Delivery System Forecasted Market Size by Region (2025-2030)
2.3 Transdermal Drug Delivery System Market Dynamics
2.3.1 Transdermal Drug Delivery System Industry Trends
2.3.2 Transdermal Drug Delivery System Market Drivers
2.3.3 Transdermal Drug Delivery System Market Challenges
2.3.4 Transdermal Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transdermal Drug Delivery System Players by Revenue
3.1.1 Global Top Transdermal Drug Delivery System Players by Revenue (2019-2024)
3.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Players (2019-2024)
3.2 Global Transdermal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transdermal Drug Delivery System Revenue
3.4 Global Transdermal Drug Delivery System Market Concentration Ratio
3.4.1 Global Transdermal Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery System Revenue in 2023
3.5 Transdermal Drug Delivery System Key Players Head office and Area Served
3.6 Key Players Transdermal Drug Delivery System Product Solution and Service
3.7 Date of Enter into Transdermal Drug Delivery System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transdermal Drug Delivery System Breakdown Data by Type
4.1 Global Transdermal Drug Delivery System Historic Market Size by Type (2019-2024)
4.2 Global Transdermal Drug Delivery System Forecasted Market Size by Type (2025-2030)
5 Transdermal Drug Delivery System Breakdown Data by Application
5.1 Global Transdermal Drug Delivery System Historic Market Size by Application (2019-2024)
5.2 Global Transdermal Drug Delivery System Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Transdermal Drug Delivery System Market Size (2019-2030)
6.2 North America Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Transdermal Drug Delivery System Market Size by Country (2019-2024)
6.4 North America Transdermal Drug Delivery System Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transdermal Drug Delivery System Market Size (2019-2030)
7.2 Europe Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Transdermal Drug Delivery System Market Size by Country (2019-2024)
7.4 Europe Transdermal Drug Delivery System Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Drug Delivery System Market Size (2019-2030)
8.2 Asia-Pacific Transdermal Drug Delivery System Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2019-2024)
8.4 Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transdermal Drug Delivery System Market Size (2019-2030)
9.2 Latin America Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Transdermal Drug Delivery System Market Size by Country (2019-2024)
9.4 Latin America Transdermal Drug Delivery System Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transdermal Drug Delivery System Market Size (2019-2030)
10.2 Middle East & Africa Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2019-2024)
10.4 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hisamitsu
11.1.1 Hisamitsu Company Detail
11.1.2 Hisamitsu Business Overview
11.1.3 Hisamitsu Transdermal Drug Delivery System Introduction
11.1.4 Hisamitsu Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.1.5 Hisamitsu Recent Development
11.2 Mylan
11.2.1 Mylan Company Detail
11.2.2 Mylan Business Overview
11.2.3 Mylan Transdermal Drug Delivery System Introduction
11.2.4 Mylan Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.2.5 Mylan Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Transdermal Drug Delivery System Introduction
11.3.4 GSK Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.3.5 GSK Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Transdermal Drug Delivery System Introduction
11.4.4 Novartis Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Teve (Actavis)
11.5.1 Teve (Actavis) Company Detail
11.5.2 Teve (Actavis) Business Overview
11.5.3 Teve (Actavis) Transdermal Drug Delivery System Introduction
11.5.4 Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.5.5 Teve (Actavis) Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Transdermal Drug Delivery System Introduction
11.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Lohmann
11.7.1 Lohmann Company Detail
11.7.2 Lohmann Business Overview
11.7.3 Lohmann Transdermal Drug Delivery System Introduction
11.7.4 Lohmann Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.7.5 Lohmann Recent Development
11.8 Teikoku Seiyaku
11.8.1 Teikoku Seiyaku Company Detail
11.8.2 Teikoku Seiyaku Business Overview
11.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Introduction
11.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.8.5 Teikoku Seiyaku Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Transdermal Drug Delivery System Introduction
11.9.4 Bayer Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.9.5 Bayer Recent Development
11.10 Lingrui
11.10.1 Lingrui Company Detail
11.10.2 Lingrui Business Overview
11.10.3 Lingrui Transdermal Drug Delivery System Introduction
11.10.4 Lingrui Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.10.5 Lingrui Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Detail
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Transdermal Drug Delivery System Introduction
11.11.4 Sanofi Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.11.5 Sanofi Recent Development
11.12 Qizheng
11.12.1 Qizheng Company Detail
11.12.2 Qizheng Business Overview
11.12.3 Qizheng Transdermal Drug Delivery System Introduction
11.12.4 Qizheng Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.12.5 Qizheng Recent Development
11.13 Endo
11.13.1 Endo Company Detail
11.13.2 Endo Business Overview
11.13.3 Endo Transdermal Drug Delivery System Introduction
11.13.4 Endo Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.13.5 Endo Recent Development
11.14 Huarun 999
11.14.1 Huarun 999 Company Detail
11.14.2 Huarun 999 Business Overview
11.14.3 Huarun 999 Transdermal Drug Delivery System Introduction
11.14.4 Huarun 999 Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.14.5 Huarun 999 Recent Development
11.15 Haw Par
11.15.1 Haw Par Company Detail
11.15.2 Haw Par Business Overview
11.15.3 Haw Par Transdermal Drug Delivery System Introduction
11.15.4 Haw Par Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.15.5 Haw Par Recent Development
11.16 Nichiban
11.16.1 Nichiban Company Detail
11.16.2 Nichiban Business Overview
11.16.3 Nichiban Transdermal Drug Delivery System Introduction
11.16.4 Nichiban Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.16.5 Nichiban Recent Development
11.17 Mentholatum
11.17.1 Mentholatum Company Detail
11.17.2 Mentholatum Business Overview
11.17.3 Mentholatum Transdermal Drug Delivery System Introduction
11.17.4 Mentholatum Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.17.5 Mentholatum Recent Development
11.18 Laboratoires Genevrier
11.18.1 Laboratoires Genevrier Company Detail
11.18.2 Laboratoires Genevrier Business Overview
11.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Introduction
11.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.18.5 Laboratoires Genevrier Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transdermal Drug Delivery System Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fentanyl
1.2.3 Nitroglycerin
1.2.4 Estradiol
1.2.5 Nicotine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Transdermal Drug Delivery System Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 OTC
1.3.3 Rx
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transdermal Drug Delivery System Market Perspective (2019-2030)
2.2 Transdermal Drug Delivery System Growth Trends by Region
2.2.1 Global Transdermal Drug Delivery System Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Transdermal Drug Delivery System Historic Market Size by Region (2019-2024)
2.2.3 Transdermal Drug Delivery System Forecasted Market Size by Region (2025-2030)
2.3 Transdermal Drug Delivery System Market Dynamics
2.3.1 Transdermal Drug Delivery System Industry Trends
2.3.2 Transdermal Drug Delivery System Market Drivers
2.3.3 Transdermal Drug Delivery System Market Challenges
2.3.4 Transdermal Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transdermal Drug Delivery System Players by Revenue
3.1.1 Global Top Transdermal Drug Delivery System Players by Revenue (2019-2024)
3.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Players (2019-2024)
3.2 Global Transdermal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transdermal Drug Delivery System Revenue
3.4 Global Transdermal Drug Delivery System Market Concentration Ratio
3.4.1 Global Transdermal Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery System Revenue in 2023
3.5 Transdermal Drug Delivery System Key Players Head office and Area Served
3.6 Key Players Transdermal Drug Delivery System Product Solution and Service
3.7 Date of Enter into Transdermal Drug Delivery System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transdermal Drug Delivery System Breakdown Data by Type
4.1 Global Transdermal Drug Delivery System Historic Market Size by Type (2019-2024)
4.2 Global Transdermal Drug Delivery System Forecasted Market Size by Type (2025-2030)
5 Transdermal Drug Delivery System Breakdown Data by Application
5.1 Global Transdermal Drug Delivery System Historic Market Size by Application (2019-2024)
5.2 Global Transdermal Drug Delivery System Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Transdermal Drug Delivery System Market Size (2019-2030)
6.2 North America Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Transdermal Drug Delivery System Market Size by Country (2019-2024)
6.4 North America Transdermal Drug Delivery System Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transdermal Drug Delivery System Market Size (2019-2030)
7.2 Europe Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Transdermal Drug Delivery System Market Size by Country (2019-2024)
7.4 Europe Transdermal Drug Delivery System Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Drug Delivery System Market Size (2019-2030)
8.2 Asia-Pacific Transdermal Drug Delivery System Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2019-2024)
8.4 Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transdermal Drug Delivery System Market Size (2019-2030)
9.2 Latin America Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Transdermal Drug Delivery System Market Size by Country (2019-2024)
9.4 Latin America Transdermal Drug Delivery System Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transdermal Drug Delivery System Market Size (2019-2030)
10.2 Middle East & Africa Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2019-2024)
10.4 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hisamitsu
11.1.1 Hisamitsu Company Detail
11.1.2 Hisamitsu Business Overview
11.1.3 Hisamitsu Transdermal Drug Delivery System Introduction
11.1.4 Hisamitsu Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.1.5 Hisamitsu Recent Development
11.2 Mylan
11.2.1 Mylan Company Detail
11.2.2 Mylan Business Overview
11.2.3 Mylan Transdermal Drug Delivery System Introduction
11.2.4 Mylan Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.2.5 Mylan Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Transdermal Drug Delivery System Introduction
11.3.4 GSK Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.3.5 GSK Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Transdermal Drug Delivery System Introduction
11.4.4 Novartis Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Teve (Actavis)
11.5.1 Teve (Actavis) Company Detail
11.5.2 Teve (Actavis) Business Overview
11.5.3 Teve (Actavis) Transdermal Drug Delivery System Introduction
11.5.4 Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.5.5 Teve (Actavis) Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Transdermal Drug Delivery System Introduction
11.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Lohmann
11.7.1 Lohmann Company Detail
11.7.2 Lohmann Business Overview
11.7.3 Lohmann Transdermal Drug Delivery System Introduction
11.7.4 Lohmann Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.7.5 Lohmann Recent Development
11.8 Teikoku Seiyaku
11.8.1 Teikoku Seiyaku Company Detail
11.8.2 Teikoku Seiyaku Business Overview
11.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Introduction
11.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.8.5 Teikoku Seiyaku Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Transdermal Drug Delivery System Introduction
11.9.4 Bayer Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.9.5 Bayer Recent Development
11.10 Lingrui
11.10.1 Lingrui Company Detail
11.10.2 Lingrui Business Overview
11.10.3 Lingrui Transdermal Drug Delivery System Introduction
11.10.4 Lingrui Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.10.5 Lingrui Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Detail
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Transdermal Drug Delivery System Introduction
11.11.4 Sanofi Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.11.5 Sanofi Recent Development
11.12 Qizheng
11.12.1 Qizheng Company Detail
11.12.2 Qizheng Business Overview
11.12.3 Qizheng Transdermal Drug Delivery System Introduction
11.12.4 Qizheng Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.12.5 Qizheng Recent Development
11.13 Endo
11.13.1 Endo Company Detail
11.13.2 Endo Business Overview
11.13.3 Endo Transdermal Drug Delivery System Introduction
11.13.4 Endo Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.13.5 Endo Recent Development
11.14 Huarun 999
11.14.1 Huarun 999 Company Detail
11.14.2 Huarun 999 Business Overview
11.14.3 Huarun 999 Transdermal Drug Delivery System Introduction
11.14.4 Huarun 999 Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.14.5 Huarun 999 Recent Development
11.15 Haw Par
11.15.1 Haw Par Company Detail
11.15.2 Haw Par Business Overview
11.15.3 Haw Par Transdermal Drug Delivery System Introduction
11.15.4 Haw Par Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.15.5 Haw Par Recent Development
11.16 Nichiban
11.16.1 Nichiban Company Detail
11.16.2 Nichiban Business Overview
11.16.3 Nichiban Transdermal Drug Delivery System Introduction
11.16.4 Nichiban Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.16.5 Nichiban Recent Development
11.17 Mentholatum
11.17.1 Mentholatum Company Detail
11.17.2 Mentholatum Business Overview
11.17.3 Mentholatum Transdermal Drug Delivery System Introduction
11.17.4 Mentholatum Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.17.5 Mentholatum Recent Development
11.18 Laboratoires Genevrier
11.18.1 Laboratoires Genevrier Company Detail
11.18.2 Laboratoires Genevrier Business Overview
11.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Introduction
11.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2019-2024)
11.18.5 Laboratoires Genevrier Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Transdermal Drug Delivery System Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Fentanyl
Table 3. Key Players of Nitroglycerin
Table 4. Key Players of Estradiol
Table 5. Key Players of Nicotine
Table 6. Key Players of Other
Table 7. Global Transdermal Drug Delivery System Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Transdermal Drug Delivery System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Transdermal Drug Delivery System Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Transdermal Drug Delivery System Market Share by Region (2019-2024)
Table 11. Global Transdermal Drug Delivery System Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Transdermal Drug Delivery System Market Share by Region (2025-2030)
Table 13. Transdermal Drug Delivery System Market Trends
Table 14. Transdermal Drug Delivery System Market Drivers
Table 15. Transdermal Drug Delivery System Market Challenges
Table 16. Transdermal Drug Delivery System Market Restraints
Table 17. Global Transdermal Drug Delivery System Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Transdermal Drug Delivery System Market Share by Players (2019-2024)
Table 19. Global Top Transdermal Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery System as of 2023)
Table 20. Ranking of Global Top Transdermal Drug Delivery System Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Transdermal Drug Delivery System Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Transdermal Drug Delivery System Product Solution and Service
Table 24. Date of Enter into Transdermal Drug Delivery System Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Transdermal Drug Delivery System Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Transdermal Drug Delivery System Revenue Market Share by Type (2019-2024)
Table 28. Global Transdermal Drug Delivery System Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Transdermal Drug Delivery System Revenue Market Share by Type (2025-2030)
Table 30. Global Transdermal Drug Delivery System Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Transdermal Drug Delivery System Revenue Market Share by Application (2019-2024)
Table 32. Global Transdermal Drug Delivery System Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Transdermal Drug Delivery System Revenue Market Share by Application (2025-2030)
Table 34. North America Transdermal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Transdermal Drug Delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Transdermal Drug Delivery System Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Transdermal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Transdermal Drug Delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Transdermal Drug Delivery System Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Transdermal Drug Delivery System Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Transdermal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Transdermal Drug Delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Transdermal Drug Delivery System Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Transdermal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2025-2030) & (US$ Million)
Table 49. Hisamitsu Company Detail
Table 50. Hisamitsu Business Overview
Table 51. Hisamitsu Transdermal Drug Delivery System Product
Table 52. Hisamitsu Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 53. Hisamitsu Recent Development
Table 54. Mylan Company Detail
Table 55. Mylan Business Overview
Table 56. Mylan Transdermal Drug Delivery System Product
Table 57. Mylan Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 58. Mylan Recent Development
Table 59. GSK Company Detail
Table 60. GSK Business Overview
Table 61. GSK Transdermal Drug Delivery System Product
Table 62. GSK Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 63. GSK Recent Development
Table 64. Novartis Company Detail
Table 65. Novartis Business Overview
Table 66. Novartis Transdermal Drug Delivery System Product
Table 67. Novartis Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Teve (Actavis) Company Detail
Table 70. Teve (Actavis) Business Overview
Table 71. Teve (Actavis) Transdermal Drug Delivery System Product
Table 72. Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 73. Teve (Actavis) Recent Development
Table 74. Johnson & Johnson Company Detail
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Transdermal Drug Delivery System Product
Table 77. Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 78. Johnson & Johnson Recent Development
Table 79. Lohmann Company Detail
Table 80. Lohmann Business Overview
Table 81. Lohmann Transdermal Drug Delivery System Product
Table 82. Lohmann Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 83. Lohmann Recent Development
Table 84. Teikoku Seiyaku Company Detail
Table 85. Teikoku Seiyaku Business Overview
Table 86. Teikoku Seiyaku Transdermal Drug Delivery System Product
Table 87. Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 88. Teikoku Seiyaku Recent Development
Table 89. Bayer Company Detail
Table 90. Bayer Business Overview
Table 91. Bayer Transdermal Drug Delivery System Product
Table 92. Bayer Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 93. Bayer Recent Development
Table 94. Lingrui Company Detail
Table 95. Lingrui Business Overview
Table 96. Lingrui Transdermal Drug Delivery System Product
Table 97. Lingrui Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 98. Lingrui Recent Development
Table 99. Sanofi Company Detail
Table 100. Sanofi Business Overview
Table 101. Sanofi Transdermal Drug Delivery System Product
Table 102. Sanofi Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 103. Sanofi Recent Development
Table 104. Qizheng Company Detail
Table 105. Qizheng Business Overview
Table 106. Qizheng Transdermal Drug Delivery System Product
Table 107. Qizheng Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 108. Qizheng Recent Development
Table 109. Endo Company Detail
Table 110. Endo Business Overview
Table 111. Endo Transdermal Drug Delivery System Product
Table 112. Endo Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 113. Endo Recent Development
Table 114. Huarun 999 Company Detail
Table 115. Huarun 999 Business Overview
Table 116. Huarun 999 Transdermal Drug Delivery System Product
Table 117. Huarun 999 Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 118. Huarun 999 Recent Development
Table 119. Haw Par Company Detail
Table 120. Haw Par Business Overview
Table 121. Haw Par Transdermal Drug Delivery System Product
Table 122. Haw Par Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 123. Haw Par Recent Development
Table 124. Nichiban Company Detail
Table 125. Nichiban Business Overview
Table 126. Nichiban Transdermal Drug Delivery System Product
Table 127. Nichiban Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 128. Nichiban Recent Development
Table 129. Mentholatum Company Detail
Table 130. Mentholatum Business Overview
Table 131. Mentholatum Transdermal Drug Delivery System Product
Table 132. Mentholatum Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 133. Mentholatum Recent Development
Table 134. Laboratoires Genevrier Company Detail
Table 135. Laboratoires Genevrier Business Overview
Table 136. Laboratoires Genevrier Transdermal Drug Delivery System Product
Table 137. Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 138. Laboratoires Genevrier Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transdermal Drug Delivery System Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Transdermal Drug Delivery System Market Share by Type: 2023 VS 2030
Figure 3. Fentanyl Features
Figure 4. Nitroglycerin Features
Figure 5. Estradiol Features
Figure 6. Nicotine Features
Figure 7. Other Features
Figure 8. Global Transdermal Drug Delivery System Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Transdermal Drug Delivery System Market Share by Application: 2023 VS 2030
Figure 10. OTC Case Studies
Figure 11. Rx Case Studies
Figure 12. Transdermal Drug Delivery System Report Years Considered
Figure 13. Global Transdermal Drug Delivery System Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Transdermal Drug Delivery System Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Transdermal Drug Delivery System Market Share by Region: 2023 VS 2030
Figure 16. Global Transdermal Drug Delivery System Market Share by Players in 2023
Figure 17. Global Top Transdermal Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery System as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery System Revenue in 2023
Figure 19. North America Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Transdermal Drug Delivery System Market Share by Country (2019-2030)
Figure 21. United States Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Transdermal Drug Delivery System Market Share by Country (2019-2030)
Figure 25. Germany Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Transdermal Drug Delivery System Market Share by Region (2019-2030)
Figure 33. China Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Transdermal Drug Delivery System Market Share by Country (2019-2030)
Figure 41. Mexico Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Transdermal Drug Delivery System Market Share by Country (2019-2030)
Figure 45. Turkey Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 48. Mylan Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 49. GSK Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 50. Novartis Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 51. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 52. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 53. Lohmann Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 54. Teikoku Seiyaku Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 55. Bayer Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 56. Lingrui Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 57. Sanofi Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 58. Qizheng Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 59. Endo Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 60. Huarun 999 Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 61. Haw Par Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 62. Nichiban Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 63. Mentholatum Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 64. Laboratoires Genevrier Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Transdermal Drug Delivery System Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Fentanyl
Table 3. Key Players of Nitroglycerin
Table 4. Key Players of Estradiol
Table 5. Key Players of Nicotine
Table 6. Key Players of Other
Table 7. Global Transdermal Drug Delivery System Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Transdermal Drug Delivery System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Transdermal Drug Delivery System Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Transdermal Drug Delivery System Market Share by Region (2019-2024)
Table 11. Global Transdermal Drug Delivery System Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Transdermal Drug Delivery System Market Share by Region (2025-2030)
Table 13. Transdermal Drug Delivery System Market Trends
Table 14. Transdermal Drug Delivery System Market Drivers
Table 15. Transdermal Drug Delivery System Market Challenges
Table 16. Transdermal Drug Delivery System Market Restraints
Table 17. Global Transdermal Drug Delivery System Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Transdermal Drug Delivery System Market Share by Players (2019-2024)
Table 19. Global Top Transdermal Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery System as of 2023)
Table 20. Ranking of Global Top Transdermal Drug Delivery System Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Transdermal Drug Delivery System Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Transdermal Drug Delivery System Product Solution and Service
Table 24. Date of Enter into Transdermal Drug Delivery System Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Transdermal Drug Delivery System Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Transdermal Drug Delivery System Revenue Market Share by Type (2019-2024)
Table 28. Global Transdermal Drug Delivery System Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Transdermal Drug Delivery System Revenue Market Share by Type (2025-2030)
Table 30. Global Transdermal Drug Delivery System Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Transdermal Drug Delivery System Revenue Market Share by Application (2019-2024)
Table 32. Global Transdermal Drug Delivery System Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Transdermal Drug Delivery System Revenue Market Share by Application (2025-2030)
Table 34. North America Transdermal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Transdermal Drug Delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Transdermal Drug Delivery System Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Transdermal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Transdermal Drug Delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Transdermal Drug Delivery System Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Transdermal Drug Delivery System Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Transdermal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Transdermal Drug Delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Transdermal Drug Delivery System Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Transdermal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2025-2030) & (US$ Million)
Table 49. Hisamitsu Company Detail
Table 50. Hisamitsu Business Overview
Table 51. Hisamitsu Transdermal Drug Delivery System Product
Table 52. Hisamitsu Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 53. Hisamitsu Recent Development
Table 54. Mylan Company Detail
Table 55. Mylan Business Overview
Table 56. Mylan Transdermal Drug Delivery System Product
Table 57. Mylan Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 58. Mylan Recent Development
Table 59. GSK Company Detail
Table 60. GSK Business Overview
Table 61. GSK Transdermal Drug Delivery System Product
Table 62. GSK Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 63. GSK Recent Development
Table 64. Novartis Company Detail
Table 65. Novartis Business Overview
Table 66. Novartis Transdermal Drug Delivery System Product
Table 67. Novartis Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Teve (Actavis) Company Detail
Table 70. Teve (Actavis) Business Overview
Table 71. Teve (Actavis) Transdermal Drug Delivery System Product
Table 72. Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 73. Teve (Actavis) Recent Development
Table 74. Johnson & Johnson Company Detail
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Transdermal Drug Delivery System Product
Table 77. Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 78. Johnson & Johnson Recent Development
Table 79. Lohmann Company Detail
Table 80. Lohmann Business Overview
Table 81. Lohmann Transdermal Drug Delivery System Product
Table 82. Lohmann Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 83. Lohmann Recent Development
Table 84. Teikoku Seiyaku Company Detail
Table 85. Teikoku Seiyaku Business Overview
Table 86. Teikoku Seiyaku Transdermal Drug Delivery System Product
Table 87. Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 88. Teikoku Seiyaku Recent Development
Table 89. Bayer Company Detail
Table 90. Bayer Business Overview
Table 91. Bayer Transdermal Drug Delivery System Product
Table 92. Bayer Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 93. Bayer Recent Development
Table 94. Lingrui Company Detail
Table 95. Lingrui Business Overview
Table 96. Lingrui Transdermal Drug Delivery System Product
Table 97. Lingrui Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 98. Lingrui Recent Development
Table 99. Sanofi Company Detail
Table 100. Sanofi Business Overview
Table 101. Sanofi Transdermal Drug Delivery System Product
Table 102. Sanofi Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 103. Sanofi Recent Development
Table 104. Qizheng Company Detail
Table 105. Qizheng Business Overview
Table 106. Qizheng Transdermal Drug Delivery System Product
Table 107. Qizheng Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 108. Qizheng Recent Development
Table 109. Endo Company Detail
Table 110. Endo Business Overview
Table 111. Endo Transdermal Drug Delivery System Product
Table 112. Endo Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 113. Endo Recent Development
Table 114. Huarun 999 Company Detail
Table 115. Huarun 999 Business Overview
Table 116. Huarun 999 Transdermal Drug Delivery System Product
Table 117. Huarun 999 Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 118. Huarun 999 Recent Development
Table 119. Haw Par Company Detail
Table 120. Haw Par Business Overview
Table 121. Haw Par Transdermal Drug Delivery System Product
Table 122. Haw Par Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 123. Haw Par Recent Development
Table 124. Nichiban Company Detail
Table 125. Nichiban Business Overview
Table 126. Nichiban Transdermal Drug Delivery System Product
Table 127. Nichiban Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 128. Nichiban Recent Development
Table 129. Mentholatum Company Detail
Table 130. Mentholatum Business Overview
Table 131. Mentholatum Transdermal Drug Delivery System Product
Table 132. Mentholatum Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 133. Mentholatum Recent Development
Table 134. Laboratoires Genevrier Company Detail
Table 135. Laboratoires Genevrier Business Overview
Table 136. Laboratoires Genevrier Transdermal Drug Delivery System Product
Table 137. Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2019-2024) & (US$ Million)
Table 138. Laboratoires Genevrier Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transdermal Drug Delivery System Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Transdermal Drug Delivery System Market Share by Type: 2023 VS 2030
Figure 3. Fentanyl Features
Figure 4. Nitroglycerin Features
Figure 5. Estradiol Features
Figure 6. Nicotine Features
Figure 7. Other Features
Figure 8. Global Transdermal Drug Delivery System Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Transdermal Drug Delivery System Market Share by Application: 2023 VS 2030
Figure 10. OTC Case Studies
Figure 11. Rx Case Studies
Figure 12. Transdermal Drug Delivery System Report Years Considered
Figure 13. Global Transdermal Drug Delivery System Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Transdermal Drug Delivery System Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Transdermal Drug Delivery System Market Share by Region: 2023 VS 2030
Figure 16. Global Transdermal Drug Delivery System Market Share by Players in 2023
Figure 17. Global Top Transdermal Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery System as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery System Revenue in 2023
Figure 19. North America Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Transdermal Drug Delivery System Market Share by Country (2019-2030)
Figure 21. United States Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Transdermal Drug Delivery System Market Share by Country (2019-2030)
Figure 25. Germany Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Transdermal Drug Delivery System Market Share by Region (2019-2030)
Figure 33. China Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Transdermal Drug Delivery System Market Share by Country (2019-2030)
Figure 41. Mexico Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Transdermal Drug Delivery System Market Share by Country (2019-2030)
Figure 45. Turkey Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Transdermal Drug Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 48. Mylan Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 49. GSK Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 50. Novartis Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 51. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 52. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 53. Lohmann Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 54. Teikoku Seiyaku Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 55. Bayer Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 56. Lingrui Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 57. Sanofi Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 58. Qizheng Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 59. Endo Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 60. Huarun 999 Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 61. Haw Par Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 62. Nichiban Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 63. Mentholatum Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 64. Laboratoires Genevrier Revenue Growth Rate in Transdermal Drug Delivery System Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232